66 results
S-3ASR
CRNX
Crinetics Pharmaceuticals Inc
19 Mar 24
Automatic shelf registration
4:05pm
or to which we have referred you. We and the selling stockholders take no responsibility for, and can provide no assurance as to the reliability of, any … of the board of trustees (or similar entity) of the Fund. Under the terms of its management contract, Janus has overall responsibility for directing
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
shall have any responsibility or liability to the Company with respect thereto. Any review by the Representatives and the other Underwriters … , and all lodging, commercial airfare and individual expenses of the Underwriters shall be the responsibility of the Underwriters); and (ix) all expenses
424B5
pvasfy5 j1e1ny7ilxb
13 Sep 23
Prospectus supplement for primary offering
5:19pm
424B5
nob3qfm9gt7a89ew8n
11 Sep 23
Prospectus supplement for primary offering
4:09pm
424B5
es7pb43 hep
12 Aug 22
Prospectus supplement for primary offering
8:31am
8-K
EX-1.1
1w2r081vtyc1
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
424B5
tcrn1zvod7kkxzl6q
13 Apr 22
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
mjt19u4ci5 xuz
5 Jan 22
Departure of Directors or Certain Officers
5:00pm
424B5
nvlphnc4d0xs
21 Oct 21
Prospectus supplement for primary offering
4:26pm